REPORT ID 1057

Global Post-Polycythemia Vera Myelofibrosis (PPV-MF) Market Research Report 2017

Publish Date
05-Dec-17
Pages
116
Format
Electronic (PDF)

In this report, the global Post-Polycythemia Vera Myelofibrosis (PPV-MF) market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Post-Polycythemia Vera Myelofibrosis (PPV-MF) in these regions, from 2012 to 2022 (forecast), covering
    North America
    Europe
    China
    Japan
    Southeast Asia
    India
Global Post-Polycythemia Vera Myelofibrosis (PPV-MF) market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer; the top players including
    AbbVie Inc
    Celgene Corp
    CTI BioPharma Corp
    F. Hoffmann-La Roche Ltd
    Gilead Sciences Inc
    Incyte Corp
    Italfarmaco SpA
    JW Pharmaceutical Corp
    MedImmune LLC
    MEI Pharma Inc
    Merck & Co Inc
    Novartis AG
    NS Pharma Inc
    Promedior Inc
    Sun Pharma Advanced Research Company Ltd
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
    Durvalumab
    Givinostat
    Glasdegib
    Idelalisib
    IMG-7289
    Others
On the basis of the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate for each application, including
    Hospital
    Clinic
    Others

If you have any special requirements, please let us know and we will offer you the report as you want.

 
			   
Table of Contents

Global Post-Polycythemia Vera Myelofibrosis (PPV-MF) Market Research Report 2017
1 Post-Polycythemia Vera Myelofibrosis (PPV-MF) Market Overview
    1.1 Product Overview and Scope of Post-Polycythemia Vera Myelofibrosis (PPV-MF)
    1.2 Post-Polycythemia Vera Myelofibrosis (PPV-MF) Segment by Type (Product Category)
        1.2.1 Global Post-Polycythemia Vera Myelofibrosis (PPV-MF) Production and CAGR (%) Comparison by Type (Product Category)(2012-2022)
        1.2.2 Global Post-Polycythemia Vera Myelofibrosis (PPV-MF) Production Market Share by Type (Product Category) in 2016
        1.2.3 Durvalumab
        1.2.4 Givinostat
        1.2.5 Glasdegib
        1.2.6 Idelalisib
        1.2.7 IMG-7289
        1.2.8 Others
    1.3 Global Post-Polycythemia Vera Myelofibrosis (PPV-MF) Segment by Application
        1.3.1 Post-Polycythemia Vera Myelofibrosis (PPV-MF) Consumption (Sales) Comparison by Application (2012-2022)
        1.3.2 Hospital
        1.3.3 Clinic
        1.3.4 Others
    1.4 Global Post-Polycythemia Vera Myelofibrosis (PPV-MF) Market by Region (2012-2022)
        1.4.1 Global Post-Polycythemia Vera Myelofibrosis (PPV-MF) Market Size (Value) and CAGR (%) Comparison by Region (2012-2022)
        1.4.2 North America Status and Prospect (2012-2022)
        1.4.3 Europe Status and Prospect (2012-2022)
        1.4.4 China Status and Prospect (2012-2022)
        1.4.5 Japan Status and Prospect (2012-2022)
        1.4.6 Southeast Asia Status and Prospect (2012-2022)
        1.4.7 India Status and Prospect (2012-2022)
    1.5 Global Market Size (Value) of Post-Polycythemia Vera Myelofibrosis (PPV-MF) (2012-2022)
        1.5.1 Global Post-Polycythemia Vera Myelofibrosis (PPV-MF) Revenue Status and Outlook (2012-2022)
        1.5.2 Global Post-Polycythemia Vera Myelofibrosis (PPV-MF) Capacity, Production Status and Outlook (2012-2022)

2 Global Post-Polycythemia Vera Myelofibrosis (PPV-MF) Market Competition by Manufacturers
    2.1 Global Post-Polycythemia Vera Myelofibrosis (PPV-MF) Capacity, Production and Share by Manufacturers (2012-2017)
        2.1.1 Global Post-Polycythemia Vera Myelofibrosis (PPV-MF) Capacity and Share by Manufacturers (2012-2017)
        2.1.2 Global Post-Polycythemia Vera Myelofibrosis (PPV-MF) Production and Share by Manufacturers (2012-2017)
    2.2 Global Post-Polycythemia Vera Myelofibrosis (PPV-MF) Revenue and Share by Manufacturers (2012-2017)
    2.3 Global Post-Polycythemia Vera Myelofibrosis (PPV-MF) Average Price by Manufacturers (2012-2017)
    2.4 Manufacturers Post-Polycythemia Vera Myelofibrosis (PPV-MF) Manufacturing Base Distribution, Sales Area and Product Type
    2.5 Post-Polycythemia Vera Myelofibrosis (PPV-MF) Market Competitive Situation and Trends
        2.5.1 Post-Polycythemia Vera Myelofibrosis (PPV-MF) Market Concentration Rate
        2.5.2 Post-Polycythemia Vera Myelofibrosis (PPV-MF) Market Share of Top 3 and Top 5 Manufacturers
        2.5.3 Mergers & Acquisitions, Expansion

3 Global Post-Polycythemia Vera Myelofibrosis (PPV-MF) Capacity, Production, Revenue (Value) by Region (2012-2017)
    3.1 Global Post-Polycythemia Vera Myelofibrosis (PPV-MF) Capacity and Market Share by Region (2012-2017)
    3.2 Global Post-Polycythemia Vera Myelofibrosis (PPV-MF) Production and Market Share by Region (2012-2017)
    3.3 Global Post-Polycythemia Vera Myelofibrosis (PPV-MF) Revenue (Value) and Market Share by Region (2012-2017)
    3.4 Global Post-Polycythemia Vera Myelofibrosis (PPV-MF) Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
    3.5 North America Post-Polycythemia Vera Myelofibrosis (PPV-MF) Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
    3.6 Europe Post-Polycythemia Vera Myelofibrosis (PPV-MF) Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
    3.7 China Post-Polycythemia Vera Myelofibrosis (PPV-MF) Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
    3.8 Japan Post-Polycythemia Vera Myelofibrosis (PPV-MF) Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
    3.9 Southeast Asia Post-Polycythemia Vera Myelofibrosis (PPV-MF) Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
    3.10 India Post-Polycythemia Vera Myelofibrosis (PPV-MF) Capacity, Production, Revenue, Price and Gross Margin (2012-2017)

4 Global Post-Polycythemia Vera Myelofibrosis (PPV-MF) Supply (Production), Consumption, Export, Import by Region (2012-2017)
    4.1 Global Post-Polycythemia Vera Myelofibrosis (PPV-MF) Consumption by Region (2012-2017)
    4.2 North America Post-Polycythemia Vera Myelofibrosis (PPV-MF) Production, Consumption, Export, Import (2012-2017)
    4.3 Europe Post-Polycythemia Vera Myelofibrosis (PPV-MF) Production, Consumption, Export, Import (2012-2017)
    4.4 China Post-Polycythemia Vera Myelofibrosis (PPV-MF) Production, Consumption, Export, Import (2012-2017)
    4.5 Japan Post-Polycythemia Vera Myelofibrosis (PPV-MF) Production, Consumption, Export, Import (2012-2017)
    4.6 Southeast Asia Post-Polycythemia Vera Myelofibrosis (PPV-MF) Production, Consumption, Export, Import (2012-2017)
    4.7 India Post-Polycythemia Vera Myelofibrosis (PPV-MF) Production, Consumption, Export, Import (2012-2017)

5 Global Post-Polycythemia Vera Myelofibrosis (PPV-MF) Production, Revenue (Value), Price Trend by Type
    5.1 Global Post-Polycythemia Vera Myelofibrosis (PPV-MF) Production and Market Share by Type (2012-2017)
    5.2 Global Post-Polycythemia Vera Myelofibrosis (PPV-MF) Revenue and Market Share by Type (2012-2017)
    5.3 Global Post-Polycythemia Vera Myelofibrosis (PPV-MF) Price by Type (2012-2017)
    5.4 Global Post-Polycythemia Vera Myelofibrosis (PPV-MF) Production Growth by Type (2012-2017)

6 Global Post-Polycythemia Vera Myelofibrosis (PPV-MF) Market Analysis by Application
    6.1 Global Post-Polycythemia Vera Myelofibrosis (PPV-MF) Consumption and Market Share by Application (2012-2017)
    6.2 Global Post-Polycythemia Vera Myelofibrosis (PPV-MF) Consumption Growth Rate by Application (2012-2017)
    6.3 Market Drivers and Opportunities
        6.3.1 Potential Applications
        6.3.2 Emerging Markets/Countries

7 Global Post-Polycythemia Vera Myelofibrosis (PPV-MF) Manufacturers Profiles/Analysis
    7.1 AbbVie Inc
        7.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.1.2 Post-Polycythemia Vera Myelofibrosis (PPV-MF) Product Category, Application and Specification
            7.1.2.1 Product A
            7.1.2.2 Product B
        7.1.3 AbbVie Inc Post-Polycythemia Vera Myelofibrosis (PPV-MF) Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.1.4 Main Business/Business Overview
    7.2 Celgene Corp
        7.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.2.2 Post-Polycythemia Vera Myelofibrosis (PPV-MF) Product Category, Application and Specification
            7.2.2.1 Product A
            7.2.2.2 Product B
        7.2.3 Celgene Corp Post-Polycythemia Vera Myelofibrosis (PPV-MF) Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.2.4 Main Business/Business Overview
    7.3 CTI BioPharma Corp
        7.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.3.2 Post-Polycythemia Vera Myelofibrosis (PPV-MF) Product Category, Application and Specification
            7.3.2.1 Product A
            7.3.2.2 Product B
        7.3.3 CTI BioPharma Corp Post-Polycythemia Vera Myelofibrosis (PPV-MF) Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.3.4 Main Business/Business Overview
    7.4 F. Hoffmann-La Roche Ltd
        7.4.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.4.2 Post-Polycythemia Vera Myelofibrosis (PPV-MF) Product Category, Application and Specification
            7.4.2.1 Product A
            7.4.2.2 Product B
        7.4.3 F. Hoffmann-La Roche Ltd Post-Polycythemia Vera Myelofibrosis (PPV-MF) Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.4.4 Main Business/Business Overview
    7.5 Gilead Sciences Inc
        7.5.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.5.2 Post-Polycythemia Vera Myelofibrosis (PPV-MF) Product Category, Application and Specification
            7.5.2.1 Product A
            7.5.2.2 Product B
        7.5.3 Gilead Sciences Inc Post-Polycythemia Vera Myelofibrosis (PPV-MF) Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.5.4 Main Business/Business Overview
    7.6 Incyte Corp
        7.6.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.6.2 Post-Polycythemia Vera Myelofibrosis (PPV-MF) Product Category, Application and Specification
            7.6.2.1 Product A
            7.6.2.2 Product B
        7.6.3 Incyte Corp Post-Polycythemia Vera Myelofibrosis (PPV-MF) Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.6.4 Main Business/Business Overview
    7.7 Italfarmaco SpA
        7.7.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.7.2 Post-Polycythemia Vera Myelofibrosis (PPV-MF) Product Category, Application and Specification
            7.7.2.1 Product A
            7.7.2.2 Product B
        7.7.3 Italfarmaco SpA Post-Polycythemia Vera Myelofibrosis (PPV-MF) Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.7.4 Main Business/Business Overview
    7.8 JW Pharmaceutical Corp
        7.8.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.8.2 Post-Polycythemia Vera Myelofibrosis (PPV-MF) Product Category, Application and Specification
            7.8.2.1 Product A
            7.8.2.2 Product B
        7.8.3 JW Pharmaceutical Corp Post-Polycythemia Vera Myelofibrosis (PPV-MF) Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.8.4 Main Business/Business Overview
    7.9 MedImmune LLC
        7.9.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.9.2 Post-Polycythemia Vera Myelofibrosis (PPV-MF) Product Category, Application and Specification
            7.9.2.1 Product A
            7.9.2.2 Product B
        7.9.3 MedImmune LLC Post-Polycythemia Vera Myelofibrosis (PPV-MF) Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.9.4 Main Business/Business Overview
    7.10 MEI Pharma Inc
        7.10.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.10.2 Post-Polycythemia Vera Myelofibrosis (PPV-MF) Product Category, Application and Specification
            7.10.2.1 Product A
            7.10.2.2 Product B
        7.10.3 MEI Pharma Inc Post-Polycythemia Vera Myelofibrosis (PPV-MF) Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.10.4 Main Business/Business Overview
    7.11 Merck & Co Inc
    7.12 Novartis AG
    7.13 NS Pharma Inc
    7.14 Promedior Inc
    7.15 Sun Pharma Advanced Research Company Ltd

8 Post-Polycythemia Vera Myelofibrosis (PPV-MF) Manufacturing Cost Analysis
    8.1 Post-Polycythemia Vera Myelofibrosis (PPV-MF) Key Raw Materials Analysis
       8.1.1 Key Raw Materials
       8.1.2 Price Trend of Key Raw Materials
       8.1.3 Key Suppliers of Raw Materials
       8.1.4 Market Concentration Rate of Raw Materials
    8.2 Proportion of Manufacturing Cost Structure
       8.2.1 Raw Materials
       8.2.2 Labor Cost
       8.2.3 Manufacturing Expenses
    8.3 Manufacturing Process Analysis of Post-Polycythemia Vera Myelofibrosis (PPV-MF)

9 Industrial Chain, Sourcing Strategy and Downstream Buyers
    9.1 Post-Polycythemia Vera Myelofibrosis (PPV-MF) Industrial Chain Analysis
    9.2 Upstream Raw Materials Sourcing
    9.3 Raw Materials Sources of Post-Polycythemia Vera Myelofibrosis (PPV-MF) Major Manufacturers in 2015
    9.4 Downstream Buyers

10 Marketing Strategy Analysis, Distributors/Traders
    10.1 Marketing Channel
        10.1.1 Direct Marketing
        10.1.2 Indirect Marketing
        10.1.3 Marketing Channel Development Trend
    10.2 Market Positioning
        10.2.1 Pricing Strategy
        10.2.2 Brand Strategy
        10.2.3 Target Client
    10.3 Distributors/Traders List

11 Market Effect Factors Analysis
    11.1 Technology Progress/Risk
        11.1.1 Substitutes Threat
        11.1.2 Technology Progress in Related Industry
    11.2 Consumer Needs/Customer Preference Change
    11.3 Economic/Political Environmental Change

12 Global Post-Polycythemia Vera Myelofibrosis (PPV-MF) Market Forecast (2017-2022)
    12.1 Global Post-Polycythemia Vera Myelofibrosis (PPV-MF) Capacity, Production, Revenue Forecast (2017-2022)
        12.1.1 Global Post-Polycythemia Vera Myelofibrosis (PPV-MF) Capacity, Production and Growth Rate Forecast (2017-2022)
        12.1.2 Global Post-Polycythemia Vera Myelofibrosis (PPV-MF) Revenue and Growth Rate Forecast (2017-2022)
        12.1.3 Global Post-Polycythemia Vera Myelofibrosis (PPV-MF) Price and Trend Forecast (2017-2022)
    12.2 Global Post-Polycythemia Vera Myelofibrosis (PPV-MF) Production, Consumption , Import and Export Forecast by Region (2017-2022)
        12.2.1 North America Post-Polycythemia Vera Myelofibrosis (PPV-MF) Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
        12.2.2 Europe Post-Polycythemia Vera Myelofibrosis (PPV-MF) Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
        12.2.3 China Post-Polycythemia Vera Myelofibrosis (PPV-MF) Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
        12.2.4 Japan Post-Polycythemia Vera Myelofibrosis (PPV-MF) Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
        12.2.5 Southeast Asia Post-Polycythemia Vera Myelofibrosis (PPV-MF) Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
        12.2.6 India Post-Polycythemia Vera Myelofibrosis (PPV-MF) Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
    12.3 Global Post-Polycythemia Vera Myelofibrosis (PPV-MF) Production, Revenue and Price Forecast by Type (2017-2022)
    12.4 Global Post-Polycythemia Vera Myelofibrosis (PPV-MF) Consumption Forecast by Application (2017-2022)

13 Research Findings and Conclusion

14 Appendix
    14.1 Methodology/Research Approach
        14.1.1 Research Programs/Design
        14.1.2 Market Size Estimation
        14.1.3 Market Breakdown and Data Triangulation
    14.2 Data Source
        14.2.1 Secondary Sources
        14.2.2 Primary Sources
    14.3 Disclaimer